These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7083201)

  • 1. Significance of aromatase activity in human breast cancer.
    Miller WR; Hawkins RA; Forrest AP
    Cancer Res; 1982 Aug; 42(8 Suppl):3365s-3368s. PubMed ID: 7083201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
    Dao TL
    Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase in the normal breast and breast cancer.
    Brodie A; Lu Q; Nakamura J
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):281-6. PubMed ID: 9365202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
    J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reassessment of the role of breast tumor aromatization.
    Bradlow HL
    Cancer Res; 1982 Aug; 42(8 Suppl):3382s-3386s. PubMed ID: 7083204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
    Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
    Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers.
    Lu Q; Nakmura J; Savinov A; Yue W; Weisz J; Dabbs DJ; Wolz G; Brodie A
    Endocrinology; 1996 Jul; 137(7):3061-8. PubMed ID: 8770932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological significance of aromatase activity in human breast tumors.
    Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
    Singer CF; Fink-Retter A; Gschwantler-Kaulich D; Thalhammer T; Hudelist G; Mueller R; Czerwenka K; Kubista E
    Endocr Relat Cancer; 2006 Dec; 13(4):1101-7. PubMed ID: 17158756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol induction of retinoic acid receptors in human breast cancer cells.
    Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
    Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.